1-6 of 6
Frank Meyskens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of combination chemoprevention on markers of cell turnover and agent action in colorectal mucosal tissue from patients in a Phase III trial of difluoromethylornithine and sulindac for prevention of colon polyp recurrence

Eugene Gerner, Frank Meyskens, Christine McLaren, Dan Pelot, Sharon Fujikawa, Philip Carpenter, Michael Lawson, Jay Kidao, John McCracken, Gregory Albers, Dennis Ahnen, Kim Turgeon, Steve Goldschmid, Peter Lance, Curt Hagedorn
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2007) 16 (12_Supplement): CN21-04.
Published: 15 August 2014
View articletitled, Effects of combination chemoprevention on markers of cell turnover and agent action in colorectal mucosal tissue from patients in a Phase III trial of difluoromethylornithine and sulindac for prevention of colon polyp recurrence
Journal Articles

Cancer Prevention for Global Health: A Report from the ASPO International Cancer Prevention Interest Group

Dejana Braithwaite, Paolo Boffetta, Timothy R. Rebbeck, Frank Meyskens
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2012) 21 (9): 1606–1610.
https://doi.org/10.1158/1055-9965.EPI-12-0848
Published: 05 September 2012
View articletitled, Cancer Prevention for Global Health: A Report from the ASPO International Cancer Prevention Interest Group
Open the PDF for Cancer Prevention for Global Health: A Report from the ASPO International Cancer Prevention Interest Group in another window
Journal Articles

Opportunities for Cancer Epidemiology and Control in Low- and Middle-Income Countries: A Report from the American Society for Preventive Oncology International Cancer Prevention Interest Group

Dejana Braithwaite, Karen J. Wernli, Hoda Anton-Culver, Paul Engstrom, E. Robert Greenberg, Frank Meyskens
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2010) 19 (7): 1665–1667.
https://doi.org/10.1158/1055-9965.EPI-10-0523
Published: 07 July 2010
View articletitled, Opportunities for Cancer Epidemiology and Control in Low- and Middle-Income Countries: A Report from the American Society for Preventive Oncology International Cancer Prevention Interest Group
Open the PDF for Opportunities for Cancer Epidemiology and Control in Low- and Middle-Income Countries: A Report from the American Society for Preventive Oncology International Cancer Prevention Interest Group in another window
Journal Articles

Cancer Following Total Joint Arthroplasty

Frank Meyskens, Jr.
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2007) 16 (2): 356.
https://doi.org/10.1158/1055-9965.EPI-06-0793
Published: 14 February 2007
View articletitled, Cancer Following Total Joint Arthroplasty
Open the PDF for Cancer Following Total Joint Arthroplasty in another window
Journal Articles

A phase II, randomized, controlled trial of the safety and efficacy of S-adenosyl-L-methionine disulphate p-toluene-sulfonate (SAMe) in reducing serum alpha-fetoprotein (AFP) in patients with hepatitis C and moderately elevated AFP.

Timothy Morgan, Sharon Maxwell, Lorene Kong, Frank Meyskens, Jr.
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2006) 15 (12_Supplement): B144.
Published: 01 December 2006
View articletitled, A phase II, randomized, controlled trial of the safety and efficacy of S-adenosyl-L-methionine disulphate p-toluene-sulfonate (SAMe) in reducing serum alpha-fetoprotein (AFP) in patients with hepatitis C and moderately elevated AFP.
Journal Articles

Molecular cancer prevention: Phase IIa trial of Erlotinib for IPMNs and the prevention of pancreatic cancer.

Steven M. Lipkin, Jessica Rhee, Jason Zell, Frank Meyskens, Ken Iwata
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2006) 15 (12_Supplement): CS04-03.
Published: 01 December 2006
View articletitled, Molecular cancer prevention: Phase IIa trial of Erlotinib for IPMNs and the prevention of pancreatic cancer.